News
3h
HealthDay on MSNFDA approves ketamine product for surgical pain management
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
Stanford University scientists have developed a brain implant designed to "hear" and vocalize words a person with severe ...
Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Former Peterborough Pete, Toronto Maple Leaf Mark Kirton dies at 67 after seven-year battle with ALS
Mark Kirton was mortal, but his attitude was “super human”, says his former junior hockey coach. The Peterborough Petes and ...
Former Detroit Red Wings forward Mark Kirton, who enjoyed the most productive seasons of his NHL career with the franchise, has tragically lost his battle against ALS and passed away Sunday at just 67 ...
Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.
Australia’s Neurizon Therapeutics saw its shares rise 10% to A$0.16 today. after it revealed that it has been informed by the ...
Former Leafs posted the news Sunday evening. Kirton, 67, was diagnosed with amyotrophic lateral sclerosis, or Lou Gehrig’s ...
4h
The Province on MSNCanucks: Hockey world mourns death of Mark Kirton after long battle with ALS
The Toronto Maple Leafs announced late on Sunday that alumnus Mark Kirton, who became a leading advocate in the fight against Amyotrophic Lateral Sclerosis (ALS), had passed away at age 67. Here's the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results